Global Human Papillomavirus (HPV) Vaccine Market Analysis

$3,500.00$7,500.00

  • Type: Common Disease Area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 238

  • Format: PPT, PDF

Global Human Papillomavirus (HPV) Vaccine Market: Segmentation by Type (Bivalent and Polyvalent), by Disease Indication (HPV Associated Cancer and Genital Warts), by Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others) and Geography Forecast, 2019-2028

Clear

Report Overview

The global Human Papillomavirus Vaccine market size stood at around USD 3.8 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.  

The need for reducing HPV infections will bode well for the market and create demand for HPV vaccines. According to the HPV Information Center, annual cases in 2018 for cervical cancer were the highest in emerging countries such as China and India, leading to the demand for vaccination camps offering doses. The governments from all the countries worldwide are keenly focused on implementing policies to help eradicate the burden of the disease. Moreover, owing to the imposition of stringent regulations, the vaccination supply has increased and is expected to rise at a faster rate during the forecast period. This increase in supply is will boost the global market

Market Drivers

Efficacy of HPV Vaccines to Accelerate the Sales: One of the most crucial and significant drivers of the market is the efficacy and protection provided by HPV vaccines to reduce the adverse effects associated with such infections. As manufacturers have developed novel vaccines of immunization, over the past years, a change in vaccination policies and beliefs have been observed worldwide. This has potentially increased the uptake and acceptability of HPV vaccines. Both bivalent and polyvalent vaccines have proved their efficacy and safety through clinical trials in protecting against HPV infections and cancer

Increasing Efforts to Meet Unmet Needs to Drive Production of HPV Vaccines: Another factor driving the market is the increase in the manufacturing capability of HPV vaccines to maintain supply-demand balance worldwide. Currently, the supply of this vaccines is insufficient to meet the existing demand. This scenario is likely to persist for a short term due to the increase in the number of countries planning to introduce HPV vaccines. For instance, in December 2018, the Ministry of Health of Ethiopia introduced the HPV vaccine through school-based approach for girls under the age group of 14 years to immunize against cervical cancer

1. Global Human Papillomavirus Vaccine Market Overview
A. Market Size
2. Market Growth Drivers………………………………
A. Efficacy of HPV Vaccines to Accelerate the Sales
B. Increasing Efforts to Meet Unmet Needs to Drive Production of HPV Vaccines
3. Major Disease Indication……………………………..
A. HPV Associated Cancer
B. Genital Warts
4. Human Papillomavirus Vaccine Market Segmentation…
A. Distribution Channel
I. Hospital & Retail Pharmacies
II. Government Suppliers
III. Others
B. Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Middle-East and Africa Market Analysis
V. South America Market Analysis
5. Human Papillomavirus Vaccine Market Share……………
A. Market Analysis, Insights and Forecast to 2028
6. Competitive Landscape…………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………
A. GlaxoSmithKline Company overview, Product & Services, Strategies & Financials
B. Merck Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………
A. New Trends and Recent Developments
B. Future Opportunities
10. Conclusion

Market Segmentation

By Indication:

On the basis of disease indication, the global market is segmented into HPV associated cancer and genital warts. Among these, the HPV associated cancer segment accounted for the highest Human Papillomavirus vaccine market share in 2019. It is also likely to emerge as the fastest growing segment during the forecast period. This dominance is attributed to the higher sales of the HPV type vaccines worldwide for immunization, mainly against cervical cancer. High-risk HPV16 and 18 strains have been maximally detected in cervical cancer patients leading to need for vaccination against these strains. The World Health Organization (WHO) says that 100% of the cervical cancers and 90% of anal cancers are caused due to HPV infections

Presently, the availability of only three HPV vaccines has led to higher demand for protection against HPV16 and HPV18 associated infections. HPV associated cancers are largely observed in females than in males. According to the Center for Disease Control and Prevention (CDC), the incidence rates for vaginal, vulva and cervical cancer was recorded the highest in the year 2018. On the other hand, genital warts account for a comparatively lower market value as the infection is thought to disappear on its own or goes unnoticeable most of the times. Genital warts, unless serious, do not require any medical treatment, though for vaccination against genital wartsare in demand

By Region:

North America generated a revenue of USD 1.83 billion in 2019 and is anticipated to dominate the global market in the forthcoming years. Higher sales value of Gardasil/Gardasil 9 and the rapid adoption of Human Papillomavirus Vaccine across the region is expected to drive the market growth in North America. Moreover, the implementation of marketing, distribution, and launching strategies by the key players ensuring higher sales has led to the dominance of North America in the global HPV vaccines market

Asia Pacific is expected to showcase the highest growth rate in the market owing to the emendation of immunization policies by the governments that further propelled the demand for HPV vaccines in the region., contributing to the rising demand for vaccine supply, coupled with the growing incidence rates of HPV disease are responsible for the growth of the Asia Pacific market. According to the HPV Information Center in 2019, annual incidence of 106,430 cervical cancer cases was recorded in China alone. Likewise, India, Southeast Asia, and other countries have also recorded high annual incidence rates in 2019. The growing prevalence of HPV associated cancer and effective implementation of HPV immunization will drive the Asia Pacific market growth during the forecast period

On the other hand, Latin America is projected to witness a significant growth in the market due to the penetration of HPV vaccines in the region and the increasing awareness among the patient pool regarding the benefits of HPV immunization. International organizations such as GAVI, PAHO, and UNICEF are also focused on providing vaccines to the needy by procuring high volume doses from manufacturers. The European market for Human Papillomavirus Vaccine is anticipated to undergo a slower growth due to a lesser prevalence of HPV associated infections and the lack of adoption of its vaccines in under-developed parts of Europe. The Middle East and Africa will witness restricted growth in the market as compared to the other key regions owing to lack of awareness about the availability and adoption of this vaccines and stringent immunization policies

Key Industry Players

The market is dominated by Merck Co., Inc and GlaxoSmithKline plc., due to their only products available in the market for the treatment of HPV infections. Also, the implementation of key distribution strategy in the developed as well as in developing nations has led to an increase in sales of both the companies. Merck has a strong portfolio of HPV vaccines that includes Gardasil and Gardasil 9. Likewise, Merck Co., Inc also has an effective HPV vaccine portfolio in competition to GSK’s portfolio. The company’s top-selling vaccines Gardasil and Gardasil 9, are factors helping Merck continue the leading position in the market competition

Moreover, the other companies are focused on launching novel vaccines in the market against different strains of human papillomavirus. Currently, Merck has three pipeline candidates in phase 3, while GSK has two pipeline candidate undergoing clinical trials

 

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements